Phenosense in Medical Technology
Phenosense in Medical Products
HIV Phenosense GT
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Phenosense in Biological Technology
Monogram Announces 2008 Third Quarter Financial Results
... revenue from Trofile(TM) for selecting HIV patients to
be treated with Selzentry(TM), Pfizer's CCR5 antagonist, and by revenue
from use of Monogram's phenosense
HIV(TM) resistance test and Trofile in a
phase III trial by a pharmaceutical company customer.
Revenue for the nine months ended September 30, 2008 ...
Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc.
...ces to the use of our resistance
assays, including phenosense
Integrase, and our Trofile Assay, the size and
tim...circumstances after the date of such statements.
GT are registered trademarks and Trofile is a
Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
...nto the DNA
of newly infected cells. Together with phenosense
Integrase provides the most comp...cture of resistance to
Integrase along with other Monogram assays were us...Phase III studies. In addition to
drug resistance, phenosense
Integrase also measures reductions in viral
Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts
...ny forward-looking statements to reflect the occurrence of
anticipated or unanticipated events or circumstances after the date of such
GT is a trademark of Monogram Biosciences, Inc.
Contacts: Alfred G. Merriweather Jeremiah Hall Chief Financial Officer Feinstein...
Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
...m's tests have been used throughout the development of the CCR5
class of drugs. In addition to the use of Trofile for patient selection and
the use of phenosense
for optimization of background therapy in the phase
II and phase III clinical trials of Pfizer's maraviroc (Selzentry(TM)) and
Schering Plough's vicri...